Question 1

Does Morgan Stanley own LYEL stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Morgan Stanley holds 37,050 shares of LYEL (Lyell Immunopharma), worth $520,553.

Question 2

How many shares of LYEL does Morgan Stanley own?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley holds 37,050 shares of LYEL (Lyell Immunopharma).

Question 3

What is Morgan Stanley's LYEL position worth?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley's LYEL position is worth $520,553.

Question 4

Is Morgan Stanley buying or selling LYEL?

Accepted Answer

In Q2 2026, Morgan Stanley reduced its LYEL position by 19,101 shares (-34.0%).

Question 5

When did Morgan Stanley first buy LYEL?

Accepted Answer

Morgan Stanley already held LYEL in its Q2 2025 13F, the earliest on record, and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	37,050	-34.0%	$520,553	0.0%	$14.05	0
2026-Q1	Increased	56,151	+30.7%	$1.1M	0.0%	$23.33	32
2025-Q4	Increased	42,949	+16.0%	$1.3M	0.0%	$31.59	29
2025-Q3	Increased	37,020	+44.1%	$601,204	0.0%	$14.97	22
2025-Q2	New	25,698	-	$227,170	0.0%	$8.94	35

LYEL5 quarters

LYEL
5 quarters